Plain-English translation of NCT07149571 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether a new type of MRI scan can better detect and measure fatty liver disease and understand how your body's metabolism is affected. Researchers want to see if this imaging technology can help predict how the disease will progress and what treatment might work best for you.
Fatty liver disease is becoming increasingly common and can lead to serious complications like cirrhosis and liver cancer. Current methods of detecting and measuring the disease are limited, so researchers are exploring whether this new imaging technology can provide better, non-invasive ways to assess disease severity and predict outcomes.
You likely qualify if…
You likely don't qualify if…
You would undergo an MRI scan using new imaging technology that the researchers are evaluating. The study involves 500 participants total, and the researchers will use the scan results to understand your liver's condition and overall metabolic health. This is an observational study, meaning researchers are mainly watching and measuring, not giving medication or other active treatments.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China
Enrollment target
~500 participants
Started
April 2025
Primary completion
December 2032
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Zhen Li
Tongji Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.